Aripiprazole lauroxil
98%
- Product Code: 54543
Alias:
Aripiprazole Lauryl Laurate; Aripiprazole Acetal Laurate, Aripiprazole Lauroyl,
CAS:
1259305-29-7
Properties:
This product is for scientific research only
| Molecular Weight: | 660.71 g./mol | Molecular Formula: | C₃₆H₅₁Cl₂N₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD26967976 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2~8°C |
Product Description:
Aripiprazole lauroxil is primarily used in the treatment of schizophrenia in adults. It is administered as a long-acting injectable formulation, providing sustained release of the active ingredient over an extended period. This makes it particularly beneficial for patients who have difficulty adhering to daily oral medication regimens. The extended-release nature of the injection helps maintain consistent therapeutic levels of the drug in the body, reducing the risk of relapse and improving overall symptom management. It is typically administered once every four to six weeks by a healthcare professional, offering a convenient option for long-term maintenance therapy. Additionally, it is used to manage acute episodes of schizophrenia and to prevent the recurrence of symptoms in stabilized patients. Its use is often considered for individuals who have responded well to oral aripiprazole but require a more manageable treatment option to ensure compliance and continuity of care.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿1,755.00 |
+
-
|
| 0.050 | 10-20 days | ฿6,066.00 |
+
-
|
| 0.100 | 10-20 days | ฿9,756.00 |
+
-
|
Aripiprazole lauroxil
Aripiprazole lauroxil is primarily used in the treatment of schizophrenia in adults. It is administered as a long-acting injectable formulation, providing sustained release of the active ingredient over an extended period. This makes it particularly beneficial for patients who have difficulty adhering to daily oral medication regimens. The extended-release nature of the injection helps maintain consistent therapeutic levels of the drug in the body, reducing the risk of relapse and improving overall symptom management. It is typically administered once every four to six weeks by a healthcare professional, offering a convenient option for long-term maintenance therapy. Additionally, it is used to manage acute episodes of schizophrenia and to prevent the recurrence of symptoms in stabilized patients. Its use is often considered for individuals who have responded well to oral aripiprazole but require a more manageable treatment option to ensure compliance and continuity of care.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :